The Heffter Research Institute sponsored study with psilocybin in clinical trials has been written about in the BBC News (Aug 15, 2004), and in the LAWeekly.
Our own Dr. David Nichols was invited to give the Keynote Page Address at the internation meeting of the Serotonin Club in Porto, Portugal in July 2004.
We mourn the recent death of LSD pioneer Dr. Betty Eisner, on July 1, 2004.
The summer 2002 progress report on the research activities sponsored by the Heffter Research Institute is available online.
The 2001 Heffter Research Awards to George Aghajanian, MD., Kenneth Alper, M.D., and Evgeny Krupitsky, M.D., Ph.D., D.Sci.
On October 24, 2001, at the University of Arizona for major funding of the study of the use of psilocybin in OCD patients. This study has received all of the regulatory and licensing approvals and is now underway.
Arvid Carlsson, M.D., Ph.D., a member of our advisory panel, was just awarded a share of the 2000 Nobel Prize in Medicine for his pioneering research into Parkinson's disease
and schizophrenia.
The 1999 Heffter Award for Outstanding Basic Research was given to Bryan L. Roth MD, PhD, Departments of Psychiatry, Biochemistry and Neurosciences at Case Western Reserve University Medical School. Dr. Roth has for many years been studying how hallucinogens bind to and regulate the activity of 5-HT receptors. Dr. Roth also directs the NIMH Drug Screening Program.
Founding members of HRI, Dr. David Nichols and Dr. Mark Geyer, traveled to Switzerland to award a research grant to Franz X. Vollenweider, M.D., and to discuss current research with Dr. Albert Hofmann.
The 1998 Heffter Research Awards were awarded to Elaine Sanders-Bush, Ph.D., and Franz X. Vollenweider, M.D., in recognition for their outstanding research .
